contact-303: primary pfs analysis of atezolizumab and cabozantinib in ccrcc
Published 1 year ago • 73 plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
3:54
papmet2: cabozantinib with or without atezolizumab in prcc
-
0:53
carina: cabozantinib post first-line immune-oncology cpi-containing combination in arcc
-
1:46
cab atezo: a new treatment for naïve advanced ccrcc
-
12:41
cabozantinib in combination with atezolizumab in patients with mcrpc
-
1:23
cabaten/getne-t1914: cabozantinib plus atezolizumab in adrenocortical carcinoma
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
1:05
cohort 1 litespark-003: belzutifan cabozantinib 1l treatment for advanced rcc
-
4:06
clinical data from the phase iii prima trial
-
2:38
checkmate 9er: cabo-nivo superior to sunitinib in extended follow-up results
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
3:32
disease control with cabozantinib plus atezolizumab in crpc - medpage today
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
2:31
asco 2022: efficacy of cabozantinib atezolizumab to treat urothelial carcinoma
-
4:12
cabosun trial of cabozantinib - could it change how we treat frontline rcc?
-
1:13
dr. agarwal on data with cabozantinib/atezolizumab in mcrpc